Insmed Statistics
NASDAQ: INSMHealth CareBiotechnology: Pharmaceutical PreparationsUSD
141.33-3.13 (-2.17%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Insmed by the numbers
Insmed has a market capitalization of $31.01 billion based on 219.38M shares outstanding. With trailing EPS of $-2.81, Insmed is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 27.2% above its 50-day average and 15.3% above its 200-day average.
Average daily trading volume is 3.09M shares, or about $436.0 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
INSM valuation vs. peer median
| Metric | INSM | Peer median | Difference |
|---|---|---|---|
| Market cap | $31.01B | $29.60B | +5% |
| Forward P/E | 220.2 | 14.5 | +1417% |
| Avg. volume | 3.09M | 3.70M | -17% |
Peer median across 8 companies: GMAB, ZTS, ROIV, UTHR, RPRX, VTRS, ALNY, ONC.
Valuation
- Market cap
- $31.01B
- Forward P/E
- 220.18
- Price / sales (latest FY)
- 51.13
- EPS (TTM)
- $-2.81
- Shares outstanding
- 219.38M
Price and trading
- Previous close
- 144.46
- Open
- 143.98
- Day range
- 140.99 – 150.00
- 52-week range
- 90.39 – 212.75
- 52-week change
- -28.89%
- 50-day moving average
- 111.09
- 200-day moving average
- 122.56
- Beta
- —
- Volume
- 6.22M
- Average volume
- 3.09M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Oct 29, 2026
Additional statistics
- Market Cap
- 31.01B
- Forward Pe
- 220.18
- Eps
- -2.81
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 212.75
- Week52 Low
- 90.39
- Avg Volume
- 3.09M
- Shares Outstanding
- 219.38M
- Ma50
- 111.09
- Ma200
- 122.56
- Earnings Date
- Oct 29, 2026
- Pct From52w High
- -33.57%
- Pct From52w Low
- 56.36%